bit simplistic imo to think this is based on comparison of phase.
look at alpine , pipeline of novel drugs , multiple studies .
Perhaps vertex decided iga nephrooathy better bet than fsg.
dimx drug a generic, very old drug version , right? can’t think of any big Pharma that would stump up billions to buy generic .
bit simplistic imo to think this is based on comparison of...
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
-0.045(7.32%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 65.0¢ | 56.5¢ | $3.477M | 5.806M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 141059 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 24687 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |